Cargando…

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease

BACKGROUND: Devil facial tumour disease (DFTD) is a fatal contagious cancer that has decimated Tasmanian devil populations. The tumour has spread without invoking immune responses, possibly due to low levels of Major Histocompatibility Complex (MHC) diversity in Tasmanian devils. Animals from a regi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lane, Amanda, Cheng, Yuanyuan, Wright, Belinda, Hamede, Rodrigo, Levan, Laura, Jones, Menna, Ujvari, Beata, Belov, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368896/ https://www.ncbi.nlm.nih.gov/pubmed/22701561 http://dx.doi.org/10.1371/journal.pone.0036955

Ejemplares similares

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association
por: Wright, Belinda, et al.
Publicado: (2017)

Anthropogenic selection enhances cancer evolution in Tasmanian devil tumours
por: Ujvari, Beata, et al.
Publicado: (2014)

Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii)
por: Ujvari, Beata, et al.
Publicado: (2016)

Untangling the model muddle: Empirical tumour growth in Tasmanian devil facial tumour disease
por: Hamede, Rodrigo K., et al.
Publicado: (2017)

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils
por: Pye, Ruth, et al.
Publicado: (2016)

MHC diversity and female age underpin reproductive success in an Australian icon; the Tasmanian Devil
por: Russell, Tracey, et al.
Publicado: (2018)

Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD)
por: Hussey, Kathryn, et al.
Publicado: (2022)

Development of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population
por: Wright, Belinda, et al.
Publicado: (2015)

Disruption of Metapopulation Structure Reduces Tasmanian Devil Facial Tumour Disease Spread at the Expense of Abundance and Genetic Diversity
por: Durrant, Rowan, et al.
Publicado: (2021)

Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells
por: Petrohilos, Cleopatra, et al.
Publicado: (2023)

Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC
por: Cheng, Yuanyuan, et al.
Publicado: (2012)

The tumour is in the detail: Local phylogenetic, population and epidemiological dynamics of a transmissible cancer in Tasmanian devils
por: Hamede, Rodrigo, et al.
Publicado: (2023)

Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
por: Bell, Olivia, et al.
Publicado: (2021)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
por: Tovar, Cesar, et al.
Publicado: (2017)

Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseases
por: Kwon, Young Mi, et al.
Publicado: (2018)

Darwin, the devil, and the management of transmissible cancers
por: Hamede, Rodrigo, et al.
Publicado: (2020)

To Lose Both Would Look Like Carelessness: Tasmanian Devil Facial Tumour Disease
por: McCallum, Hamish, et al.
Publicado: (2006)

Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii)
por: Raven, Nynke, et al.
Publicado: (2022)

Transmissible cancer and longitudinal telomere dynamics in Tasmanian devils (Sarcophilus harrisii)
por: Madsen, Thomas, et al.
Publicado: (2022)

Major Histocompatibility Complex (MHC) Markers in Conservation Biology
por: Ujvari, Beata, et al.
Publicado: (2011)

Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
por: Deakin, Janine E., et al.
Publicado: (2012)

Spatial variation in gene expression of Tasmanian devil facial tumors despite minimal host transcriptomic response to infection
por: Kozakiewicz, Christopher P., et al.
Publicado: (2021)

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells
por: Ong, Chrissie E. B., et al.
Publicado: (2019)

Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells
por: Fernandez-Rojo, Manuel A., et al.
Publicado: (2018)

Tasmanian devils with contagious cancer exhibit a constricted T-cell repertoire diversity
por: Cheng, Yuanyuan, et al.
Publicado: (2019)

Rapid evolutionary response to a transmissible cancer in Tasmanian devils
por: Epstein, Brendan, et al.
Publicado: (2016)

Identification of candidate genes for devil facial tumour disease tumourigenesis
por: Taylor, Robyn L., et al.
Publicado: (2017)

Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease
por: Espejo, Camila, et al.
Publicado: (2021)

Age‐related variation in the trophic characteristics of a marsupial carnivore, the Tasmanian devil Sarcophilus harrisii
por: Bell, Olivia, et al.
Publicado: (2020)

Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
por: Tovar, Cesar, et al.
Publicado: (2018)

Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity
por: Kreiss, Alexandre, et al.
Publicado: (2011)

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
por: Patchett, Amanda L., et al.
Publicado: (2016)

Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes
por: Ingles, Emory D., et al.
Publicado: (2015)

The Tasmanian devil microbiome—implications for conservation and management
por: Cheng, Yuanyuan, et al.
Publicado: (2015)

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014)

The Genomic Basis of Tumor Regression in Tasmanian Devils (Sarcophilus harrisii)
por: Margres, Mark J, et al.
Publicado: (2018)

The devil is in the details: Genomics of transmissible cancers in Tasmanian devils
por: Storfer, Andrew, et al.
Publicado: (2018)

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release
por: Pye, Ruth, et al.
Publicado: (2018)

Restoring faith in conservation action: Maintaining wild genetic diversity through the Tasmanian devil insurance program
por: Farquharson, Katherine A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ht98j8ufh8lvqq0nscfph3r23a